How Boston spinouts run customer discovery for university and biotech ideas

What to take away

Why Boston spinouts interview customers before they incorporate

Boston's spinout pipeline runs on federal money and institutional patience. A lab here can hold a patent, a paper and a grant, and still have no customer. Customer discovery interviews are how founders find out whether anyone outside the lab cares.

The local reason is density. Longwood, Kendall Square and the BU and Northeastern corridors put hospital administrators, payers, contract manufacturers and pharma scouts within a short train ride. A founder can book ten conversations in a fortnight without flying anywhere.

Federal R&D funding routes for deep-tech validation, including SBIR and STTR, reward teams that can describe a buyer. Program officers read the commercialization section closely. Interviews give you the sentences that section needs.

Delaware incorporation is cheap and fast, and most Boston spinouts register there while operating in Massachusetts. That paperwork does not ask who your customer is. Investors and licensing managers do, and they ask early.

Before you commit to either, know what a customer interview can measure and what it cannot. A conversation cannot tell you your market size or your price. It can tell you whose week gets worse without your product.

How university licensing offices structure discovery conversations

Every Boston university licensing office runs some version of the same sequence. The names differ, the order rarely does.

At MIT, the Technology Licensing Office publishes standard startup license terms and expects founders to name a lead customer or pilot partner. Harvard's Office of Technology Development runs a similar gate through its startup process, with hospital-adjacent teams at Mass General Brigham often following a parallel track.

BU's Technology Development office and Tufts' Office of Technology Transfer and Industry Collaboration work the same way at smaller scale. A licensing officer will ask how many customer conversations you have had and what changed after each one.

That question is where most founders stall. If you cannot say what a call changed, the officer hears a pitch, not evidence. Read the customer interviews framework with a sceptical eye before you answer it.

Biotech commercialization programs and the questions they insist on

Biotech is slower than software, so its discovery questions are different. Boston's commercialization programs, including the Blavatnik Biomedical Accelerator at Harvard, the Deshpande Center at MIT and MassBio's mentoring and investor programs, push on four things.

Who pays. In the United States, a therapeutic has to survive Medicare, Medicaid and commercial coverage. A hospital pharmacist or a payer medical director is a real interview subject, not a proxy.

Who signs. A department chief, a pharmacy director and a purchasing group can all block a purchase. Find out which one holds the budget line.

What the current standard of care costs. Ask what the clinic does today, what it pays for that, and what it would drop to adopt something new.

What the regulatory path looks like. A 510(k) and a biologic license application imply different timelines, different trial costs and different partners. Program mentors will ask which one you are on.

Deep tech validation also means talking to people who will never buy. A contract manufacturer, a toxicologist and a regulatory consultant are worth an hour each. They tell you what will break before a buyer does.

Keep a running list of customer interview answers and the follow-up you sent. Program mentors ask for it, and so do seed investors.

SBIR Lab2Market and FAST as validation scaffolding

The SBIR Lab2Market program for university and biotech spinout validation is designed for exactly this gap. It funds teams to test commercial assumptions while the science is still in the lab, and it expects customer interviews as an output, not a side effect.

SBIR FAST, the Federal and State Technology partnership, supports state and local innovation programs that coach small firms through proposal writing and commercialization. In Massachusetts, that money reaches founders through state and regional support organizations rather than a single office.

Together they cover the two halves of a Boston spinout: proving the idea has a market, and proving the team can win federal funding to build it. Neither replaces a conversation with a buyer.

About half of the value is the deadline. A Lab2Market milestone forces you to book interviews you would otherwise postpone until after the next experiment.

Use the federal programs as scaffolding, not as proof. A grant is not a purchase order, and reviewers are not customers. For a comparison of methods, see online survey vs customer interviews when you decide how to test a claim at scale.

Recording discovery so it survives the spinout paperwork

Notes taken in a lab notebook will not survive a licensing negotiation. Build one file from day one and keep it in a place your co-founders can reach.

Tag each note with the assumption it tests. When a licensing officer or an SBIR reviewer asks how you know, you can point at the row.

Here is a worked example. A Boston lab with a sepsis diagnostic ran twelve interviews in six weeks. Four were with ICU physicians, three with hospital lab directors, three with sepsis quality leads and two with a purchasing manager.

The lab directors said the test was too slow for the current workflow. The team changed the claim from faster diagnosis to faster antibiotic de-escalation and rewrote its one-pager. That change came from one interview, not from the science.

Most customer interview mistakes happen before the call starts, usually in who you pick and what you ask. Fix the list before you fix the script.

Boston licensing and local support for a new entity

Once the interviews point to a real buyer, the administrative work starts. In Boston, that means a city business certificate from the City Clerk, and a Massachusetts employer identification number application with the state Department of Revenue.

You will also need a federal employer identification number from the IRS. If you operate as a sole proprietor while testing, Schedule C is where the early costs land. Delaware entity registration remains the common choice for the spinout itself.

Small Business | Boston.gov lists the licenses, permits and local support a new Boston entity needs, including small business assistance and neighborhood liaison contacts. Use it before you sign a lab or office lease.

The wider Massachusetts network includes the Small Business Development Centers hosted through regional offices, SCORE free mentoring, and SBA district office programs. They are free, and most have seen a university spinout before.

One caution from the FTC: advertising claims and endorsements have rules, and a customer quote used in a pitch deck or on a site can count as an endorsement. Keep the consent, and keep it accurate.

Common questions